Intrexon Corporation

Precigen is a commercial-stage biopharmaceutical company focused on delivering highly targeted precision medicines to treat difficult-to-treat diseases with high unmet patient needs. They are known for their innovative therapies like PAPZIMEOS™, approved in the US for subcutaneous injection.